Pfizer’s Prevnar 20 May Have Edge Over Merck’s Pneumococcal Vaccine, ACIP Suggests

Pneumococcal vaccine
CDC advisory committee asseses Pfizer and Merck pneumococcal vaccines • Source: Alamy

More from US FDA Performance Tracker

More from Regulatory Trackers